Triomics raises $22 million to streamline cancer care with AI
Triomics, a health care AI startup, just raised $22 million to make life easier for both doctors and cancer patients.
Their platform uses AI to speed up things like matching patients with clinical trials and prepping for appointments (basically, it takes on the boring data work so clinicians can focus on care).
Big names like Battery Ventures, Nexus Venture Partners, Lightspeed, and Y Combinator are backing them.
Triomics expands clinical tools, quadruples customers
Since launching in 2021, Triomics has gone from just finding clinical trials to building tools that help doctors quickly summarize years of patient records.
Top cancer centers like Memorial Sloan Kettering and Yale Cancer Center already use their tech.
The platform also automates tumor report submissions (a legal must-do), cutting down paperwork and helping fight burnout among medical staff.
Over the past year alone, Triomics has quadrupled its customer base and seen annualized recurring revenue jump 10-fold — a sign that hospitals are seriously on board.